Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
mucopolysaccharidosis 1 endocrinologydiseases
Fabry disease 1 endocrinologydiseases
lysosomal storage disease 1 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
Fabry disease 8317 thickening in MPS is less important than in other storage diseases, such as Pompe disease or Anderson- Fabry disease . Thus, it is important to regularly measure wall thickness, left ventricular dimensions, and cardiac
lysosomal storage disease 3539 disease phenotypes have not been recognized yet by other specialists. The mainstay of MPS, as for all lysosomal storage disease s, is “early diagnosis-early management”, and a correct interpretation of clinical and laboratory
mucopolysaccharidosis 4021 been proposed (Table 1, Figs. 1 and 2) [[2]].Table 1Ten-point checklist for cardiologists to suspect mucopolysaccharidosis 1. Family history: consanguinity and/or X-linked inheritance (female to male; no male to male transmission)Yes/No2.

You must be authorized to submit a review.